Opzelura (Ruxolitinib) Approval Status, Uses, and Key Facts
healthcare
Opzelura is a prescription topical treatment indicated for nonsegmental vitiligo in people aged twelve years and older. It belongs to a class of medicines known as Janus kinase...
Open article